The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Negative Pressure Wound Therapy in the Management of Diabetic Foot Ulcers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04093635
Recruitment Status : Unknown
Verified September 2019 by Abdelrahman Ibrahim Sayed, Assiut University.
Recruitment status was:  Not yet recruiting
First Posted : September 18, 2019
Last Update Posted : September 18, 2019
Sponsor:
Information provided by (Responsible Party):
Abdelrahman Ibrahim Sayed, Assiut University

Tracking Information
First Submitted Date September 16, 2019
First Posted Date September 18, 2019
Last Update Posted Date September 18, 2019
Estimated Study Start Date November 2019
Estimated Primary Completion Date November 2020   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: September 16, 2019)
Management of diabetic foot ulcers. [ Time Frame: one year ]
Assessment role of negative pressure wound therapy in treating diabetic foot ulcers.
Original Primary Outcome Measures Same as current
Change History No Changes Posted
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Negative Pressure Wound Therapy in the Management of Diabetic Foot Ulcers
Official Title Role of Negative Pressure Wound Therapy in the Management of Diabetic Foot Ulcers
Brief Summary

Role of Negative Pressure Wound Therapy in the Management of Diabetic Foot Ulcers

• The aim of this study will be to assess negative pressure wound therapy in treating diabetic foot ulcers.

Detailed Description

Diabetic Foot ulcers are a major cause of admission in diabetic patients, and comprise a disproportionately high number of hospital days because of multiple surgical procedures and prolonged length of stay in Hospital.

The improvement in diabetes therapy and the reinforcement of guidelines have reduced the amputation rate. The approach to diabetic foot ulcers has allowed the availability of several medical options to ensure the best local condition and wound healing.

Negative-pressure wound therapy is a non-invasive therapy system that employs a controlled negative pressure using a vacuum device to promote wound healing by removing fluid from open wounds through a sealed dressing or a foam dressing connected to a container.

An earlier study has shown that NPWT reduced the need for subsequent amputations in a 6-month follow-up period. This reflects the importance of this device in management of DFUs and prevents its complications.

As most of the diabetic wounds present with infection, the success of NPWT is still highly dependent upon the adequacy of surgical debridement and antimicrobial coverage.

NPWT provides a moist wound environment ideal for re-epithelialization, growth factor action, angiogenesis, and granulation promotion.

Edema reduction produced by NPWT decreases interstitial pressure and positively promoting wound vessel formation and improving wound circulation and lymphatic drainage, increasing the availability of nutrients, oxygen and antibiotic therapy in the wound area. Some studies showed that NPWT promotes an improvement of balance between proteases and their inhibitors and influences cytokine modulation and promotes a positive wound environment.

Accurate classification of diabetic foot ulcers according to Wagner's classification of ulcers is essential for inter-clinician communication, assessment of healing tendency during management by NPWT.

Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Probability Sample
Study Population

The study population will include patients diagnosed as DFU from November 2019 to November 2020 at Assiut University Hospital.

The patients will divide into two groups:

Group I: Those patients that will be treated by NPWT. Group II: Those patients will be treated with standard saline moist wound care and dressing.

Each group consists of 20 patients.

Condition Diabetic Foot Ulcer
Intervention Device: Negative Pressure Wound Therapy
VAC was applied by placing sterile pads in two layers with a 16Fr Ryle's tube placed between the two layers and then the wound was sealed by a sterile transparent polyurethane sheet. The tube was connected to a wall-mounted suction device and the pressure will be set at -125 mmHg Mode of NPWT. This dressing will be changed every 72 hrs
Study Groups/Cohorts
  • Group I
    Those patients that will be treated by NPWT.
    Intervention: Device: Negative Pressure Wound Therapy
  • Group II
    Those patients will be treated with standard saline moist wound care and dressing.
    Intervention: Device: Negative Pressure Wound Therapy
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Unknown status
Estimated Enrollment
 (submitted: September 16, 2019)
40
Original Estimated Enrollment Same as current
Estimated Study Completion Date January 2021
Estimated Primary Completion Date November 2020   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Acute and chronic diabetic wounds, pressure ulcers.
  • Wagener's Grade I superficial diabetic ulcer.
  • Wagener's Grade II after surgical debridement and an appropriate antibiotic therapy.
  • Ischemic wounds after revascularization.

Exclusion Criteria:

  • - Wagener's Grade III, osteomyelitis and Charcot's joint septic arthritis.
  • Wagener's Grade IV, localized gangrene e.g. toe ,heel.
  • Wagener's Grade V, extensive gangrene involving the whole foot.
  • Septicemia. .
  • Gas forming organism.
  • Wounds resulting from venous insufficiency.
  • Peripheral vascular disease (absent distal pulse).
  • Patients being treated with corticosteroids, immunosuppressive drugs or chemotherapy
  • Any other serious pre-existing cardiovascular, pulmonary and immunological disease.
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years to 80 Years   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Not Provided
Removed Location Countries  
 
Administrative Information
NCT Number NCT04093635
Other Study ID Numbers VAC in DFUs
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement Not Provided
Current Responsible Party Abdelrahman Ibrahim Sayed, Assiut University
Original Responsible Party Same as current
Current Study Sponsor Assiut University
Original Study Sponsor Same as current
Collaborators Not Provided
Investigators Not Provided
PRS Account Assiut University
Verification Date September 2019